Clicky

Health

Health Canada Authorizes Moderna’s Omicron-Targeting Bivalent COVID-19 Booster Vaccine

1200 277 Robert

Study results show mRNA-1273.214 has demonstrated significantly higher antibody titers against Omicron BA.1 and BA.4/5 subvariants when compared with mRNA-1273 Approval follows agreement with the Government of Canada to supply 12 million doses of Omicron-targeting…

Therapeutic Goods Administration Provisionally Approves Moderna’s Omicron-Containing Bivalent Booster Candidate, MRNA-1273.214, For Australia

1200 277 Tori

Australia becomes among the first countries in the world to approve the use of a next-generation bivalent COVID-19 vaccine mRNA-1273.214, an Omicron-containing bivalent vaccine, has demonstrated significantly higher antibody titers against all tested variants, including…

Therapeutic Goods Administration Grants Provisional Approval for Moderna’s COVID-19 Vaccine in Children Aged Six Months to Five Years

1200 277 Robert

CAMBRIDGE, MA / ACCESSWIRE / July 18, 2022 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the Therapeutic Goods Administration (TGA) in Australia has granted provisional registration…

Moderna and the European Commission Agree on Amendment to COVID-19 Vaccine Supply Agreement

1200 277 admin

CAMBRIDGE, MA / ACCESSWIRE / June 2, 2022 / Moderna, Inc.(NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced an agreement with the European Commission (EC) to amend their originally agreed contractual…

Empower Clinics Granted Accreditation For Mobile Covid-19 Testing Solutions Throughout British Columbia

270 50 Robert

VANCOUVER, BC / ACCESSWIRE / May 26, 2022 / EMPOWER CLINICS INC (CSE:CBDT)(Frankfurt:8EC)(OTCQB:EPWCF) (“Empower” or the “Company“) an integrated healthcare company – serving patients through medical centers, telemedicine platforms, a medical device company, and a high…

IAVI and Moderna Launch First-in-Africa Clinical Trial of mRNA HIV Vaccine Development Program

1200 277 Merci

Phase I trial in Rwanda and South Africa aims to evaluate mRNA HIV vaccine antigen for safety and immunogenicity and strengthen regional scientific capacity NEW YORK, NY and CAMBRIDGE, MA / ACCESSWIRE / May 18,…

Moderna to Host Annual Science and Technology Day on May 17, 2022

1200 277 Merci

CAMBRIDGE, MA / ACCESSWIRE / May 9, 2022 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that that it will host its in-person Science and Technology Day for…

Moderna Files to Expand Conditional Marketing Authorization for Its COVID-19 Vaccine to Include Children Six Months to Under Six Years in The European Union

1200 277 Merci

The filing follows the European Medicines Agency’s Committee for Medicinal Products for Human Use recent decision to adopt a positive opinion recommending marketing authorization for Moderna’s COVID-19 vaccine to include children six years of age and older.…

Bangladesh Society Recognizes COVID-19 Humanitarian Efforts Between United States and Bangladesh

1443 1056 Todd

Zahid F. Sarder Saddi has been involved in the Bangladeshi-American Community for over 25 years. He is an influential civil society leader who advocates for COVID-19 vaccine donations toward Bangladesh. NEW YORK, NY / ACCESSWIRE…

Altamira Therapeutics Announces Peer-Reviewed Publication on Positive in vitro Data with its Bentrio(TM) Drug-Free Nasal Spray Against SARS-CoV-2 Delta Variant

320 110 Merci

Study Confirms in vitro Efficacy / Safety of Bentrio(TM) for Delta Variant Prophylactic treatment of human nasal mucosa with Bentrio™ was reported to significantly reduce the viral titer vs. controls over 4 days, reaching a…